nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—bone cancer	0.92	1	CbGaD
Conivaptan—Phlebitis—Carboplatin—bone cancer	0.00381	0.054	CcSEcCtD
Conivaptan—Deferasirox—CYP3A4—bone cancer	0.00329	0.352	CrCbGaD
Conivaptan—Electrocardiogram ST segment depression—Epirubicin—bone cancer	0.003	0.0425	CcSEcCtD
Conivaptan—Electrocardiogram ST segment depression—Doxorubicin—bone cancer	0.00278	0.0393	CcSEcCtD
Conivaptan—Lomitapide—CYP3A4—bone cancer	0.0026	0.278	CrCbGaD
Conivaptan—Tolvaptan—CYP3A4—bone cancer	0.00232	0.248	CrCbGaD
Conivaptan—Infection—Carboplatin—bone cancer	0.0016	0.0227	CcSEcCtD
Conivaptan—Pain—Carboplatin—bone cancer	0.00138	0.0195	CcSEcCtD
Conivaptan—Body temperature increased—Carboplatin—bone cancer	0.00127	0.0181	CcSEcCtD
Conivaptan—Atorvastatin—CYP3A4—bone cancer	0.00113	0.121	CrCbGaD
Conivaptan—Phlebitis—Cisplatin—bone cancer	0.00112	0.0158	CcSEcCtD
Conivaptan—Polyuria—Cisplatin—bone cancer	0.0011	0.0155	CcSEcCtD
Conivaptan—Oral candidiasis—Epirubicin—bone cancer	0.00107	0.0152	CcSEcCtD
Conivaptan—Hypomagnesaemia—Epirubicin—bone cancer	0.00107	0.0152	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—bone cancer	0.000992	0.0141	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—bone cancer	0.000992	0.0141	CcSEcCtD
Conivaptan—Hyponatraemia—Cisplatin—bone cancer	0.000966	0.0137	CcSEcCtD
Conivaptan—Dehydration—Cisplatin—bone cancer	0.000895	0.0127	CcSEcCtD
Conivaptan—Orthostatic hypotension—Cisplatin—bone cancer	0.000879	0.0125	CcSEcCtD
Conivaptan—Hypokalaemia—Cisplatin—bone cancer	0.000876	0.0124	CcSEcCtD
Conivaptan—Urine output increased—Methotrexate—bone cancer	0.000658	0.00932	CcSEcCtD
Conivaptan—Urinary tract disorder—Cisplatin—bone cancer	0.000658	0.00932	CcSEcCtD
Conivaptan—Urethral disorder—Cisplatin—bone cancer	0.000653	0.00925	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—bone cancer	0.00065	0.00921	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—bone cancer	0.000631	0.00895	CcSEcCtD
Conivaptan—Cardiac disorder—Cisplatin—bone cancer	0.000618	0.00876	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—bone cancer	0.000602	0.00853	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—bone cancer	0.000602	0.00853	CcSEcCtD
Conivaptan—Mediastinal disorder—Cisplatin—bone cancer	0.0006	0.00851	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—bone cancer	0.000591	0.00837	CcSEcCtD
Conivaptan—Erythema—Cisplatin—bone cancer	0.00058	0.00822	CcSEcCtD
Conivaptan—Malnutrition—Cisplatin—bone cancer	0.00058	0.00822	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—bone cancer	0.000574	0.00813	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—bone cancer	0.000547	0.00775	CcSEcCtD
Conivaptan—Anaemia—Cisplatin—bone cancer	0.000536	0.00759	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—bone cancer	0.000531	0.00752	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—bone cancer	0.000506	0.00718	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—bone cancer	0.000506	0.00718	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—bone cancer	0.000496	0.00703	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00049	0.00695	CcSEcCtD
Conivaptan—Infection—Cisplatin—bone cancer	0.00047	0.00666	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—bone cancer	0.000469	0.00664	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—bone cancer	0.000469	0.00664	CcSEcCtD
Conivaptan—Nervous system disorder—Cisplatin—bone cancer	0.000464	0.00658	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—bone cancer	0.00046	0.00652	CcSEcCtD
Conivaptan—Skin disorder—Cisplatin—bone cancer	0.00046	0.00651	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—bone cancer	0.000459	0.00651	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—bone cancer	0.000451	0.0064	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—bone cancer	0.00045	0.00638	CcSEcCtD
Conivaptan—Hypotension—Cisplatin—bone cancer	0.000442	0.00627	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—bone cancer	0.000425	0.00603	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—bone cancer	0.000418	0.00592	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—bone cancer	0.000416	0.0059	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—bone cancer	0.000409	0.0058	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cisplatin—bone cancer	0.000408	0.00579	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—bone cancer	0.000407	0.00577	CcSEcCtD
Conivaptan—Infestation—Methotrexate—bone cancer	0.000407	0.00577	CcSEcCtD
Conivaptan—Pain—Cisplatin—bone cancer	0.000405	0.00573	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—bone cancer	0.000395	0.00559	CcSEcCtD
Conivaptan—Feeling abnormal—Cisplatin—bone cancer	0.00039	0.00553	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—bone cancer	0.000388	0.0055	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—bone cancer	0.000385	0.00546	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—bone cancer	0.000383	0.00543	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—bone cancer	0.000381	0.0054	CcSEcCtD
Conivaptan—Infestation—Epirubicin—bone cancer	0.000381	0.0054	CcSEcCtD
Conivaptan—Body temperature increased—Cisplatin—bone cancer	0.000374	0.0053	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—bone cancer	0.00037	0.00525	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—bone cancer	0.000365	0.00518	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—bone cancer	0.000363	0.00515	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—bone cancer	0.000361	0.00511	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—bone cancer	0.000358	0.00508	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—bone cancer	0.000357	0.00505	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—bone cancer	0.000355	0.00502	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—bone cancer	0.000352	0.005	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—bone cancer	0.000352	0.005	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—bone cancer	0.000343	0.00486	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—bone cancer	0.000339	0.00481	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—bone cancer	0.000338	0.00479	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—bone cancer	0.000337	0.00477	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—bone cancer	0.000336	0.00476	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—bone cancer	0.000335	0.00475	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—bone cancer	0.000332	0.0047	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—bone cancer	0.000329	0.00467	CcSEcCtD
Conivaptan—Diarrhoea—Cisplatin—bone cancer	0.000324	0.00459	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—bone cancer	0.00032	0.00454	CcSEcCtD
Conivaptan—Erythema—Methotrexate—bone cancer	0.000318	0.00451	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—bone cancer	0.000318	0.00451	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—bone cancer	0.000317	0.0045	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—bone cancer	0.000312	0.00443	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—bone cancer	0.000312	0.00442	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—bone cancer	0.00031	0.0044	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—bone cancer	0.00031	0.0044	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—bone cancer	0.000308	0.00437	CcSEcCtD
Conivaptan—Vomiting—Cisplatin—bone cancer	0.000301	0.00426	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—bone cancer	0.0003	0.00425	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—bone cancer	0.000298	0.00422	CcSEcCtD
Conivaptan—Erythema—Epirubicin—bone cancer	0.000298	0.00422	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—bone cancer	0.000294	0.00417	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—bone cancer	0.000294	0.00416	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—bone cancer	0.000287	0.00407	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—bone cancer	0.000285	0.00404	CcSEcCtD
Conivaptan—Nausea—Cisplatin—bone cancer	0.000281	0.00398	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—bone cancer	0.000277	0.00393	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—bone cancer	0.000275	0.0039	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—bone cancer	0.000275	0.0039	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—bone cancer	0.000275	0.0039	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000269	0.00381	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—bone cancer	0.000262	0.00371	CcSEcCtD
Conivaptan—Infection—Methotrexate—bone cancer	0.000258	0.00366	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—bone cancer	0.000257	0.00364	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—bone cancer	0.000255	0.00361	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—bone cancer	0.000255	0.00361	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—bone cancer	0.000252	0.00357	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000252	0.00357	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—bone cancer	0.000248	0.00351	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—bone cancer	0.000245	0.00347	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—bone cancer	0.000243	0.00344	CcSEcCtD
Conivaptan—Infection—Epirubicin—bone cancer	0.000241	0.00342	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—bone cancer	0.000238	0.00338	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—bone cancer	0.000238	0.00337	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—bone cancer	0.000236	0.00334	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—bone cancer	0.000235	0.00333	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000233	0.0033	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—bone cancer	0.000229	0.00325	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—bone cancer	0.000227	0.00322	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—bone cancer	0.000227	0.00321	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—bone cancer	0.000224	0.00318	CcSEcCtD
Conivaptan—Infection—Doxorubicin—bone cancer	0.000223	0.00317	CcSEcCtD
Conivaptan—Pain—Methotrexate—bone cancer	0.000222	0.00315	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—bone cancer	0.00022	0.00312	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—bone cancer	0.00022	0.00311	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—bone cancer	0.000218	0.00309	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.00303	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—bone cancer	0.00021	0.00298	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—bone cancer	0.00021	0.00297	CcSEcCtD
Conivaptan—Constipation—Epirubicin—bone cancer	0.000208	0.00294	CcSEcCtD
Conivaptan—Pain—Epirubicin—bone cancer	0.000208	0.00294	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—bone cancer	0.000205	0.00291	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—bone cancer	0.000203	0.00288	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.00284	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000194	0.00275	CcSEcCtD
Conivaptan—Pain—Doxorubicin—bone cancer	0.000192	0.00272	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—bone cancer	0.000192	0.00272	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—bone cancer	0.000192	0.00272	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.00263	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—bone cancer	0.000184	0.0026	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—bone cancer	0.000178	0.00252	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—bone cancer	0.000178	0.00252	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—bone cancer	0.000172	0.00244	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00236	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—bone cancer	0.000165	0.00234	CcSEcCtD
Conivaptan—Headache—Methotrexate—bone cancer	0.000163	0.0023	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—bone cancer	0.000159	0.00225	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—bone cancer	0.000154	0.00219	CcSEcCtD
Conivaptan—Nausea—Methotrexate—bone cancer	0.000154	0.00219	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.00218	CcSEcCtD
Conivaptan—Headache—Epirubicin—bone cancer	0.000152	0.00216	CcSEcCtD
Conivaptan—Nausea—Epirubicin—bone cancer	0.000144	0.00205	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—bone cancer	0.000143	0.00203	CcSEcCtD
Conivaptan—Headache—Doxorubicin—bone cancer	0.000141	0.002	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—bone cancer	0.000134	0.00189	CcSEcCtD
